Overview
With remarkable achievements in healthcare and pharmaceutical innovation, Asia has developed rapidly and the region is a major engine of global economic growth. This year, DIA CoRE Singapore Annual Meeting aims to showcase recent trends in innovation launched in Asia or therapeutics focused on disease prevalent in this region. Asia will impact the R&D landscape and global pharmaceutical, while regulatory developments and the quality of partnerships plays an important role on how the industry grows. Come join us and be a part of discussion to explore the steps required for Asia to be at the forefront of the healthcare evolution.
Featured
Want to learn more about DIA CoRE Singapore Annual Meeting 2023 Asia at the Forefront of the Healthcare Evolution ? You've come to the right site!
Program Committee
-
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore -
Audrey Ooi, MSc Head- Business Development
Clinical Research Malaysia, Malaysia -
Helene Sou, MSc, RAC Global Regulatory Policy and Innovation
Takeda Pharmaceutical Company Limited., Singapore -
Jack Wong Founder
ARPA (Asia Regulatory Professionals Association) , Singapore -
Sannie S Foong Chong, PhD Senior Director, Global Regulatory Policy
MSD International, Singapore -
Senthil Sockalingam Head of Medical Affairs, APAC
BeiGene, Singapore -
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore -
Vicky Hsu Senior Vice President, Head of Project Leadership and Biotech Operations Asia
Parexel International, Singapore -
Martin Lim, MBA, MS Co-Founder and CEO
ONWARD Health Research, Singapore -
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Jing Ping Yeo, PhD Global Head, Project Operations & Head, Transformation
George Clinical, Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Fengyun (Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
Have an account?